Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Menopause. 2011 Nov;18(11):1184–1190. doi: 10.1097/gme.0b013e31821d6d33

Table 3.

Sleep Problems at Follow-Up by HT Suspension Group

Continuation Group (n = 518) 1-Month Suspension Group (n = 452) 2-Month Suspension Group (n = 435) 1-Month versus Continuation 2-Months versus Continuation

mean (SD) mean (SD) mean (SD) Difference (95% CI) Difference (95% CI)
Sleep quality index (average number of days; range 0 – 7) 2.7 (1.5) 3.1 (1.6) 3.4 (1.6) 0.49 (0.29, 0.69) 0.70 (0.50, 0.91)

mean (SD) mean (SD) mean (SD) IRR a (95% CI) IRR a (95% CI)

Sleep characteristics (average number of days; range 0 – 7)
 Trouble falling asleep 1.3 (1.7) 1.6 (2.0) 2.0 (2.1) 1.23 (1.05, 1.46) 1.46 (1.24, 1.73)
 Waking while sleeping 4.4 (2.4) 5.0 (2.3) 5.2 (2.3 ) 1.14 (1.07, 1.21) 1.17 (1.10, 1.25)
 Waking too early 2.5 (2.4) 3.1 (2.5) 3.3 (2.5) 1.24 (1.10, 1.40) 1.31 (1.16, 1.48)
 Sleeping Poorly 2.3 (2.2) 3.1 (2.5) 3.4 (2.4) 1.36 (1.22, 1.52) 1.46 (1.31, 1.62)
 Unsatisfied with sleep 3.6 (2.4) 4.0 (2.4) 4.3 (2.2) 1.12 (1.03, 1.22) 1.20 (1.10, 1.30)
 Not rested when woke up 3.4 (2.3) 3.9 (2.3) 4.1 (2.2) 1.15 (1.06, 1.24) 1.20 (1.10, 1.30)
 Too little sleep 2.5 (2.2) 2.9 (2.5) 3.0 (2.4) 1.17 (1.04, 1.32) 1.21 (1.07, 1.37)

n (%) n (%) n (%) RR b (95% CI) RRb (95% CI)

Sleep characteristics (reporting any days)
Using sleep aids
 yes 170 (33.0) 136 (30.4) 137 (31.6) 0.89 (0.68, 1.17) 0.94 (0.71, 1.23)
 no 345 (67.0) 311 (69.6) 296 (68.4)
Falling asleep at unscheduled times
 yes 254 (49.7) 234 (52.4) 244 (56.4) 1.11 (0.86, 1.41) 1.31 (1.01,1.69)
 no 257 (50.3) 213 (47.7) 189 (43.7)
a

IRR=Incidence rate ratio, for sleep outcomes measured in the number of days

b

RR=Relative risk, for binary sleep outcomes